Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells

Lancet

Volumn 354, Issue 9184, 1999, Pages 1092-1093

  Reiffers, Josy ^a   Cailliot, Christian ^d   Dazey, Bernard ^b   Attal, Michel ^c   Caraux, Jean ^d   Boiron, Jean Michel ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b Etablissement de Transfus S   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d Amgen SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MELPHALAN; MYELOABLATIVE AGENT;

ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOPOIETIC CELL; HOSPITALIZATION; HUMAN; MORBIDITY; MYELOMA; NEUTROPENIA; PRIORITY JOURNAL; STEM CELL; WHOLE BODY RADIATION;

EID: 0033604074     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03113-X     Document Type: Article

References (5)

1. Brugger W., Heimfeld S., Berenson R.J., Meterlsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. 2N Engl J Med. 333:1995;283-287.
2. Williams S.F., Lee W.J., Bender J.G.et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood. 87:1996;1687-1691.
3. Andrews R.G., Bridell R.A., Gough M., McNiece I.K. Expansion of G-CSF mobilized CD34+ peripheral blood cells (PBC) for 10 days in G-CSF, MBDF and SCF prior transplantation decreased post-transplantation neutropenia in baboons. Blood. 80:1997;405. (abstr).
4. Attal M., Harousseau J.L. Autologus peripheral blood progenitor cell transplantation for multiple myeloma. Baillère's Clin Haematol. 1999;. (in press).
5. Facon T., Harousseau J.L., Maloisel F.et al. Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial. Blood. 94:1999;1218-1225.